Studies have shown that EZH2 reduces autophagic cell death in aortic VSMCs by inhibiting autophagosomes formation through ATG5 and ATG7 repression, thereby supporting VSMC survival during AD (Li et al., 2018). This evidence concerns the gene ATG5 and Alzheimer disease.